Evidence map›Paper›PMID 23572482›Full record

Trial reportClinical infectious diseases : an official publication of the Infectious Diseases Society of America2013

Discontinuation of contact precautions for methicillin-resistant staphylococcus aureus: a randomized controlled trial comparing passive and active screening with culture and polymerase chain reaction.

Erica S Shenoy, Jiyeon Kim, Eric S Rosenberg, Jessica A Cotter, Hang Lee, Rochelle P Walensky, David C Hooper

Registry-linked trialOpen access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01234831 (A Novel Approach to MRSA Screening of Colonized Patients and Impact on Hospital Resource Allocation and Patient Care), which is not on this map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01234831 nacompletednot on this map

A Novel Approach to MRSA Screening of Colonized Patients and Impact on Hospital Resource Allocation and Patient Care

TypeinterventionalSponsorMassachusetts General HospitalRan2010 to 2016Enrolled463ConditionsMRSA ColonizationArmsnucleic acid amplification of nasal swab, nasal swab culture, Nasal swab culture
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Emergence ofASM case reports · 2026
    Article
  6. Article
  7. Epidemiology and control of meticillin-resistant Staphylococcus aureus in Stockholm County, Sweden, 2000 to 2016: overview of a "search-and-contain" strategy.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Isolation Precautions in the Inpatient Setting.Hospital medicine clinics · 2016
    Review
  14. Article
  15. Article
  16. Utilization management in microbiology.Clinica chimica acta; international journal of clinical chemistry · 2014
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Erica S ShenoyMassachusetts General Hospital, Division of Infectious Diseases and Infection Control Unit, 55 Fruit St, Bulfinch 340, Boston, MA 02114, USA. eshenoy@partners.org
Jiyeon Kim
Eric S Rosenberg
Jessica A Cotter
Hang Lee
Rochelle P Walensky
David C Hooper
Harvard University · USCancer Research And Biostatistics · USMassachusetts General Hospital · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
Harvard Clinical and Translational Science Center (UL1)UL1TR000170 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2012 to 2013
$31.4M
INFECTIOUS DISEASE AND BASIC MICROBIOLOGICAL MECHANISMST32AI007061 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Marcia B Goldberg · 1985 to 2026
$12.1M
NCATS NIH HHS 8UL1TR000170-05NCATS NIH HHS UL1 TR000170NCRR NIH HHS 1 UL1 RR025758NCRR NIH HHS UL1 RR025758NIAID NIH HHS L30 AI090926NIAID NIH HHS T32 AI007061PHS HHS T32 A107061
6 · The paper itself

Abstract

backgroundThere have been no randomized controlled trials comparing active and passive screening for documenting clearance of colonization with methicillin-resistant Staphylococcus aureus (MRSA). We compared the efficacy of active and passive screening using both culture and commercial polymerase chain reaction (PCR) for documentation of MRSA clearance and discontinuation of MRSA contact precautions (CPs).

methodsInpatients with a history of MRSA infection or colonization enrolled between December 2010 and September 2011 were randomized to either passive (nonintervention arm; n = 202; observation with local standard of care) or active screening (intervention arm; n = 405; study staff screened using culture and commercial PCR). The primary outcome was discontinuation of CPs by trial arm based on 3 negative cultures. In the intervention arm, sensitivity, specificity, and positive and negative predictive values of the first PCR were compared to cultures.

resultsCPs were discontinued significantly more often (rate ratio [RR], 4.1; 95% confidence interval [CI], 2.3%-7.1%) in the intervention arm, including in an intent-to-screen analysis (RR, 2.6; 95% CI, 1.5%-4.7%). The first PCR, compared to 3 cultures, detected MRSA with a sensitivity of 93.9% (95% CI, 85.4%-97.6%), a specificity of 92.0% (95% CI, 85.9%-95.6%), a positive predictive value of 86.1% (95% CI, 75.9%-93.1%), and a negative predictive value of 96.6% (95% CI, 91.6%-99.1%).

conclusionsCompared to passive screening using culture methods, active screening resulted in discontinuation of MRSA CPs at a significantly higher frequency. Active screening with a single PCR would significantly increase the completion of the screening process. Clinical Trials Registration. NCT01234831.

Indexed as

AdultAgedAged, 80 and overBacteriological TechniquesFemaleHumansMaleMass ScreeningMethicillin-Resistant Staphylococcus aureusMiddle AgedMolecular Diagnostic TechniquesPolymerase Chain ReactionPredictive Value of TestsSensitivity and SpecificityStaphylococcal Infectionsclinical trialcontact precautionsinfection controlisolationMRSA

Identifiers

PMID23572482
PMCPMC3689342
OpenAlexW2111314661

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.